Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Editas Medicine Inc patents


Recent patent applications related to Editas Medicine Inc. Editas Medicine Inc is listed as an Agent/Assignee. Note: Editas Medicine Inc may have other listings under different names/spellings. We're not affiliated with Editas Medicine Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Editas Medicine Inc-related inventors


Systems and methods for one-shot guide rna (ogrna) targeting of endogenous and source dna

Engineered nucleic acids encoding genome editing system components are provided, as are engineered rna-guided nucleases that include inserts encoded in part by cellular genomic or other sequences recognized by guide rnas.. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)

Crispr/cas-related compositions and methods for treatment of leber's congenital amaurosis 10 (lca10) are disclosed.. . ... Editas Medicine Inc

Compositions and methods for treating cep290-associated disease

Compositions and methods for treatment of cep290 related diseases are disclosed.. . ... Editas Medicine Inc

Evaluation of cas9 molecule/guide rna molecule complexes

Disclosed herein are methods for evaluation, selection, optimization, and design of cas9 molecule/grna molecule complexes.. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating hiv infection and aids

Crispr/cas-related systems, compositions and methods for editing ccr5 and/or cxcr4 genes in human cells are described, as are cells and compositions including cells edited according to the same.. . ... Editas Medicine Inc

Crispr-cas-related methods, compositions and components for cancer immunotherapy

Crispr/cas-related composition and methods for treatment of cancer, in particular by using grna molecules comprising a targeting domain which is complementary with a target domain from the fas, bid, ctla4, pdcd1, cblb, ptpn6, trac or trbc gene. In some embodiments, grnas are used with cas9 enzymes to cause a cleavage event in said genes within engineered chimeric antigen receptor (car) t cells. ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)

Crispr/cas-related compositions and methods for treatment of hsv-1 are disclosed.. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa

Crispr/cas-related compositions and methods for treatment of usher syndrome and/or retinitis pigmentosa are disclosed herein.. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating primary open angle glaucoma

Crispr/cas-related compositions and methods for treatment of primary open angle glaucoma (poag) are disclosed.. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating cystic fibrosis

Crispr/cas-related compositions and methods for treatment of cystic fibrosis (cf).. . ... Editas Medicine Inc

Crispr/cas-related methods and compositions for treating hiv infection and aids

Crispr/cas-related compositions and methods for treatment of a subject at risk for or having a hiv infection or aids are disclosed.. . ... Editas Medicine Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Editas Medicine Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Editas Medicine Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###